Immediate Impact
54 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Bispecific antibodies: advancing precision oncology
2024 Standout
Works of Michael Xie being referenced
LC-MS characterization and purity assessment of a prototype bispecific antibody
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Xie | 111 | 56 | 64 | 62 | 26 | 276 | |
| Arif Şanlı | 54 | 52 | 91 | 19 | 32 | 329 | |
| Mehmet Eken | 63 | 13 | 72 | 17 | 24 | 216 | |
| Jorge Rodrigues | 33 | 13 | 76 | 50 | 20 | 245 | |
| Mariko Ishida | 7 | 68 | 22 | 29 | 31 | 335 | |
| Zhaohui Shi | 15 | 139 | 21 | 56 | 30 | 330 | |
| Hironobu Nishijima | 51 | 32 | 91 | 64 | 37 | 309 | |
| Hideya Iijima | 17 | 107 | 32 | 46 | 16 | 336 | |
| Ergün Sevil | 91 | 15 | 94 | 10 | 26 | 306 | |
| Sasan Dabiri | 149 | 15 | 78 | 11 | 38 | 285 | |
| Nofrat Schwartz | 28 | 70 | 54 | 7 | 23 | 327 |
All Works
Login with ORCID to disown or claim papers
Loading papers...